Key Takeaways From Inari Medical Analyst Ratings
Latest Ratings for NARI DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for NARI View the Latest Analyst Ratings